Phase 1 Chronic Graft Versus Host Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

Chronic Graft Versus Host Disease

Stefanie Sarantopoulos, MD, PhD.30 enrolled1 locationNCT06233110

Recruiting

Phase 1Phase 2

Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy

Chronic Graft Versus Host Disease

Yujun DONG24 enrolled1 locationNCT07012304